What you need to know about - Johnson & Johnson
2 小时之前 · This morning, Johnson & Johnson shared its 2024 fourth-quarter and full-year earnings report. Since its founding in 1886, the company has been committed to innovation—today, more than 130,000 employees across the globe work to deliver solutions for patients around the world to help profoundly impact health for humanity.
Johnson & Johnson reports Q4 2024 and Full-Year 2024 results
14 小时之前 · New Brunswick, N.J. (January 22, 2025) – Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2024. “2024 was a transformative year for Johnson & Johnson, marked by strong growth, an accelerating pipeline and industry-leading investments in innovation,” said Joaquin Duato, Chairman and Chief Executive Officer, Johnson & …
Latest news - Johnson & Johnson
A collection of stories that highlight the way Johnson & Johnson is making an impact in the lives of its consumers, and the latest press releases from the company.
Johnson & Johnson Earnings Narrowly Top But Dow Giant's Sales …
1 小时前 · In premarket trades on the stock market today, Johnson & Johnson stock lost 1.2%. Shares rose 0.8% to 148.15 on Tuesday, coming up to a falling 50-day moving average.
Johnson & Johnson announces FDA approves sNDA for Spravato
1 天前 · Johnson & Johnson announced the U.S. FDA approval of a supplemental New Drug Application for Spravato CIII nasal spray, making this innovative treatment the first and only monotherapy for adults ...
Investor Relations | Johnson & Johnson
2025年1月15日 · At Johnson & Johnson, we believe health is everything. We are building a world where complex diseases are prevented, treated and cured, treatments are smarter and less invasive and solutions are personal. ... You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information ...
J&J advances $6.475 billion settlement of talc cancer lawsuits - CNN
2024年5月1日 · Johnson & Johnson is moving forward with a $6.475 billion proposed settlement of tens of thousands of lawsuits alleging that its baby powder and other talc products contain asbestos and cause...
Johnson & Johnson Reports Q3 2024 Results | Johnson & Johnson
2024年10月15日 · NEW BRUNSWICK, N.J.-- (BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) today announced results for third-quarter 2024. “Johnson & Johnson’s strong results in the third quarter reflect the unique breadth of our business and commitment to delivering the next wave of healthcare innovation,” said Joaquin Duato, Chairman and Chief Executive Officer.
Johnson & Johnson | AP News - Associated Press News
2024年1月23日 · Johnson & Johnson will spend more than $14 billion to move deeper into treating central nervous system disorders by purchasing Intra-Cellular Therapies. FDA says that decongestant in many cold medicines doesn’t work. So what does? Do I need a booster if I got the Johnson & Johnson vaccine?
What J&J’s Now $9 Billion Settlement Offer Means for
2024年9月6日 · Johnson & Johnson’s proposed settlement for its ongoing baby powder litigation has increased as it nears finalization. The pharmaceutical giant has tacked an additional $1.1 billion onto the $6.48 billion ovarian cancer settlement that it initially proposed in May.